Northwest Biotherapeutics (NWBO) Non-Current Assets: 2009-2025
Historic Non-Current Assets for Northwest Biotherapeutics (NWBO) over the last 17 years, with Sep 2025 value amounting to $23.4 million.
- Northwest Biotherapeutics' Non-Current Assets fell 2.98% to $23.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.4 million, marking a year-over-year decrease of 2.98%. This contributed to the annual value of $22.7 million for FY2024, which is 4.52% down from last year.
- According to the latest figures from Q3 2025, Northwest Biotherapeutics' Non-Current Assets is $23.4 million, which was up 0.08% from $23.4 million recorded in Q2 2025.
- Northwest Biotherapeutics' 5-year Non-Current Assets high stood at $24.1 million for Q3 2024, and its period low was $19.2 million during Q1 2021.
- In the last 3 years, Northwest Biotherapeutics' Non-Current Assets had a median value of $23.4 million in 2025 and averaged $23.4 million.
- As far as peak fluctuations go, Northwest Biotherapeutics' Non-Current Assets skyrocketed by 245.17% in 2021, and later dropped by 11.77% in 2022.
- Quarterly analysis of 5 years shows Northwest Biotherapeutics' Non-Current Assets stood at $22.9 million in 2021, then dropped by 4.25% to $21.9 million in 2022, then increased by 8.41% to $23.7 million in 2023, then dropped by 4.52% to $22.7 million in 2024, then fell by 2.98% to $23.4 million in 2025.
- Its Non-Current Assets stands at $23.4 million for Q3 2025, versus $23.4 million for Q2 2025 and $22.8 million for Q1 2025.